Obesity-associated cardiovascular risk and benefit from PCSK9 inhibition: a prespecified analysis from FOURIER
Kang YM, Giugliano RP, Keech AC, et al.
J Am Coll Cardiol. Pub. online 10 Dec 2025.
Leggi
Kang YM, Giugliano RP, Keech AC, et al.
J Am Coll Cardiol. Pub. online 10 Dec 2025.
Leggi
Barker MM, Slater T, Melanie J. Davies, et al.
Nutr Metab Cardiovasc Dis. Pub. online 13 Dec 2025.
Leggi
Candido R, Buzzetti R, Consoli A, et al.
Acta Diabetol. Pub. online 3 Dec 2025.
Leggi
The CHMP adopted an extension to an existing indication as follows: Mounjaro is indicated for the treatment of adults, adolescents and children aged 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
11 dicembre 2025
Leggi
Wang Y, Ram J, Bianchi, C et al.
Diabetologia. Pub. online 12 Dec 2025.
Leggi
Beck RW, Hirsch IB, Raghinaru D, et al.
Diabetes Care. Pub. online 5 Dec 2025.
Leggi
Wang Y, Wang S, Wang W, et al.
Diabetes Obes Metab. Pub. online 4 Dec 2025.
Leggi
Ardakani J, Shahid I, Gullapelli R, et al.
JAMA Netw Open. Pub. online 1 Dec 2025.
Leggi
Schoenaker D, Dyer E, Heslehurst N, et al.
Diabet Med. Pub. online 7 Dec 2025.
Leggi
Brinkmann MLS, Krasilnikoff NJ, Chaaban MA, et al.
Diabet Med. Pub. online 7 Dec 2025.
Leggi